Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2629

1.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

PMID:
17462167
[PubMed - indexed for MEDLINE]
Free Article
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.

Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A.

Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190. Review.

PMID:
17927922
[PubMed - indexed for MEDLINE]
Free Article
4.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

PMID:
15147610
[PubMed - indexed for MEDLINE]
Free Article
5.

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Unwin N, Shaw J, Zimmet P, Alberti KG.

Diabet Med. 2002 Sep;19(9):708-23. Review.

PMID:
12207806
[PubMed - indexed for MEDLINE]
6.

The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.

Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G.

Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. Review.

PMID:
17018228
[PubMed - indexed for MEDLINE]
Free Article
7.

Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.

Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, Taylor R, Watkin P, Fonseca S, Davis A, Hind S.

Health Technol Assess. 2007 Aug;11(32):1-168, iii-iv. Review.

PMID:
17683682
[PubMed - indexed for MEDLINE]
Free Article
8.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

PMID:
15842952
[PubMed - indexed for MEDLINE]
Free Article
10.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
11.

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA.

Health Technol Assess. 2000;4(29):1-123. Review.

PMID:
11109029
[PubMed - indexed for MEDLINE]
Free Article
12.

[Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].

Flórez H.

Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish.

PMID:
9235072
[PubMed - indexed for MEDLINE]
13.

Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.

Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J.

Health Technol Assess. 2004 Apr;8(13):iii, ix-x, 1-91. Review.

PMID:
15038907
[PubMed - indexed for MEDLINE]
Free Article
14.

The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.

Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, Ayres J, Bain L, Thomas S, Godden D, Waugh N.

Health Technol Assess. 2006 Jan;10(3):iii-iv, ix-x, 1-90. Review.

PMID:
16409881
[PubMed - indexed for MEDLINE]
Free Article
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
16.

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M, Black C, Boroujerdi M, Jick S, Wyness L, McNamee P, Brennan A, Waugh N.

Health Technol Assess. 2012 Aug;16(33):1-236, iii-iv. doi: 10.3310/hta16330. Review.

PMID:
22935084
[PubMed - indexed for MEDLINE]
Free Article
17.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
18.

A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.

Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. Review.

PMID:
17134597
[PubMed - indexed for MEDLINE]
Free Article
19.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

PMID:
16595080
[PubMed - indexed for MEDLINE]
Free Article
20.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

PMID:
16409879
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk